潜在的临床试验,以推进免疫检查点抑制剂毒性的研究
Christopher Cluxton1,2, Jarushka Naidoo1,2,3
1Beaumont Hospital, RCSI Cancer Centre, D09 V2N0 Dublin, Ireland.
Current oncology (Toronto, Ont.)
|July 28, 2023
概括
免疫检查点抑制剂 (ICI) 提供持久的抗瘤反应,但会增加与免疫相关的不良事件 (IRAE). 本审查审查了临床试验,以建立基于证据的指导方针来管理ICI毒性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 临床药理学 临床药理学
背景情况:
- 免疫检查点抑制剂 (ICI) 是有效的癌症疗法,在许多恶性瘤中诱导持久反应.
- 广泛使用ICI导致免疫相关不良事件 (IRAE) 的增加.
- 目前的IRAE管理指南缺乏可靠的证据,依赖于追溯数据和案例系列.
研究的目的:
- 审查目前的临床试验环境,以管理IRAEs.
- 确定开发ICI相关毒性标准化,基于证据的管理算法的机会.
主要方法:
- 对调查免疫相关不良事件管理的临床试验的系统审查.
- 对ICI引起的毒性现有文献和指导方针的分析.
主要成果:
- 目前对IRAE的管理主要基于回顾性研究的有限证据.
- 需要进行前性随机对照试验,以建立最终的管理策略.
- 临床试验正在出现,以解决对标准化IRAE管理的需求.
结论:
- 基于随机对照试验的标准化管理算法对于优化ICI的安全性和有效性至关重要.
- 进一步的研究和临床试验对于完善IRAE治疗方案至关重要.
- 基于证据的指导方针将改善患者的治疗结果,并促进更广泛地采用ICI治疗.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
相关概念视频
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
